NASDAQ$SERA
Sera Prognostics Inc-A · Q2 2025 earnings
Q2 2025 earnings · · After market close · Investor relations
Briefing
Sera Prognostics Inc-A reported Q2 2025 results showing minimal revenue and continued net losses amid ongoing commercialization efforts.
For the three months ended June 30, 2025, the company recorded revenue of $17,000 and a net loss of $8.0 million. Operating expenses totaled $9.3 million, driven by research and development, selling and marketing, and general and administrative costs. Cash and cash equivalents stood at $5.0 million with total assets of $111.8 million at quarter end.
- Revenue for Q2 2025 was $17,000, down from $24,000 in Q2 2024.
- Net loss narrowed slightly to $8.0 million from $8.3 million year-over-year.
- Cash position improved to $5.0 million from $4.0 million at year-end 2024 following equity offering.
- Total assets reached $111.8 million, supported by marketable securities and recent financing.
Headline financials
Revenue & EPS history
Sera Prognostics · Revenue · Quarterly
$17K
Forward guidance
The company expects continued operating losses while focusing on PreTRM test commercialization and pipeline development, with cash runway sufficient through 2028.
Tailwinds
- Cash runway extended through 2028 based on current operating plans.
- Recent equity offering provided $53.6 million in net proceeds.
- Clinical evidence from PRIME and AVERT studies supports potential market adoption.
Headwinds
- Ongoing net losses and limited revenue generation.
- Dependence on third-party payers for reimbursement remains uncertain.
- Commercial expansion requires additional investment in sales and marketing.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports
-1.9%
Avg return
Earnings day
-3.5%
Avg return
5 days after
-3.3%
Avg return
30 days after
36%
8 / 22 earnings
Positive
+14.3%
Q3 2022
Best reaction
-11.7%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2025 | — | — | — | |
| Q1 2026 | -3.7% | -8.0% | +18.1% | |
| Q4 2025 | -7.7% | +6.3% | +20.4% | |
| Q3 2025 | +1.7% | +8.5% | +19.0% | |
| Q1 2025 | -11.7% | -2.1% | -35.4% | |
| Q4 2024 | -5.1% | -2.2% | -17.9% | |
| Q3 2024 | -0.3% | -2.7% | -3.9% | |
| Q2 2024 | +0.0% | -1.2% | -2.2% | |
| Q1 2024 | +3.3% | -4.0% | -13.6% | |
| Q4 2023 | +3.4% | +1.1% | +7.7% | |
| Q3 2023 | -3.2% | -6.4% | +130.9% | |
| Q2 2023 | +0.8% | -10.1% | -39.9% | |
| Q1 2023 | -0.8% | -2.8% | -13.0% | |
| Q4 2022 | -10.0% | -9.5% | -22.3% | |
| Q3 2022 | +14.3% | +11.1% | -4.0% | |
| Q2 2022 | -4.1% | -6.3% | -27.3% | |
| Q1 2022 | -7.6% | -17.1% | -32.7% | |
| Q4 2021 | +3.6% | +0.3% | -39.3% | |
| Q3 2021 | +0.3% | -0.8% | -8.2% | |
| Q3 2020 | +0.3% | -0.8% | -8.2% | |
| Q1 2021 | -4.8% | -9.9% | +0.0% | |
| Q2 2021 | -4.8% | -9.9% | +0.0% | |
| Q4 2020 | -4.8% | -9.9% | +0.0% | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro